The very first CST-Astellas T3 (Transformative Thinking in Transplant) Competition – a contest aimed at inspiring innovative solutions in transplant care – was launched today by Astellas Pharma Canada Inc., and the Canadian Society of Transplantation (CST).
The ultimate goal of the T3 competition is to advance long-term health outcomes and quality of life for Canadian transplant patients.
Through the competition, Astellas and the CST hope to identify and support delivery of plausible implementation solutions in the areas of patient care, education, adherence, organ donation, and quality of life improvement.
“Astellas Pharma Canada is proud to support the inaugural T3 Competition, recognizing that medication alone is not enough to support transplant recipients and their families,” said Neil Sarin, director of the hospital business unite of Astellas. “As our company marks twenty years of innovation in immunosuppressive therapy, we want to turn the spotlight on the Canadian transplant community for all that they do to ensure Canada remains at the forefront of innovation in transplantation.”
The T3 competition is a “dynamic departure” from the typical clinical research supported by CST and provides a forum for new ideas, according to Dr. Atul Humar, president of the CST.
The CST is a professional organization for physicians, surgeons, scientists and allied health professionals working in the field of transplantation. The group has more than 500 members from across the country in all transplant fields, in clinical practice and scientific research.
“T3 opens the door to innovative solutions focused on improving the patient and caregiver journey through the full, often complex experience of a transplant,” said Humar.
The competition is open to members in good standing of the CSTwho have novel ideas that will help support individuals on a waiting list for a new organ, live donors, transplant recipients, healthcare professionals, caregivers as well as other stakeholders.
Three grants including a grand prize of $50,000 and two finalist prizes of $25,000 each will be awarded to help bring these new innovations to life.
The finalists, as selected by a panel of transplant experts, will present their ideas at an event to be held during the 2017 CST-CTRMS Joint Scientific Meeting in Halifax, Nova Scotia. The winners will be selected by the live audience.
For details on submissions and competition eligibility, visit www.cst-transplant.ca